Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Merck & Co Inc. (MRK)

Nine Major Drugmakers Agree To Lower Drug Prices Through TrumpRx Initiative 12/19/2025 8:45:40 PM

Merck Reaches Agreement With U.S. Government To Expand Access To Medicines And Lower Costs For Americans 12/19/2025 4:13:30 PM

Merck's CAPVAXIVE Added To Publicly Funded Adult Immunization Program In Saskatchewan 12/8/2025 7:15:33 AM

Merck’s CAPVAXIVE Added To Saskatchewan’s Publicly Funded Adult Immunization Program 12/8/2025 7:05:23 AM

Merck Unit Gets FDA Conditional Approval For EXZOLT CATTLE-CA1 To Treat Key Cattle Parasites 12/4/2025 8:29:15 PM

Formycon, MS Pharma In Deal To Commercialize Keytruda Biosimilar Candidate FYB206 In MENA Region 12/4/2025 12:46:33 AM

Antengene: China Approves IND For ATG-022 Combo Study With Merck's KEYTRUDA 12/2/2025 5:20:04 AM

Merck Presents New Alzheimer's Candidates Data At CTAD 2025 Today 12/1/2025 10:43:22 AM

FDA Approves First And Only ADC And PD-1 Inhibitor Regimen For Certain Patients With Bladder Cancer 11/24/2025 2:44:57 AM

Pfizer : FDA Oks PADCEV + Keytruda Combo For Cisplatin-Ineligible Muscle-Invasive Bladder Cancer 11/21/2025 11:01:01 PM

Merck Urges Shareholders To Reject Unsolicited Mini-Tender Offer From Tutanota LLC 11/21/2025 10:28:10 PM

Merck Recommends Rejection Of Tutanota's $65.00/shr Mini-Tender Offer 11/21/2025 8:39:34 PM

FDA Approves Merck’s KEYTRUDA With Padcev As First PD-1 + ADC Option For Cisplatin-Ineligible MIBC Patients 11/21/2025 4:40:55 PM

Merck Canada And Pan-Canadian Pharmaceutical Alliance Complete Negotiations For WINREVAIR 11/20/2025 7:21:58 AM

Merck Declares Quarterly Dividend Of $0.85/share, Payable Jan. 8/ Record Dec. 15 11/18/2025 11:47:37 AM

Merck's WINREVAIR Meets Primary Endpoint In Phase 2 CADENCE Study, Stock Up In Pre-Market 11/18/2025 7:32:22 AM

Merck Announces Positive Topline Results From Phase 2 CADENCE Study Of WINREVAIR 11/18/2025 6:48:06 AM

Merck To Acquire Cidara For $221.50/shr 11/14/2025 7:15:17 AM

Merck To Acquire Cidara For $221.50/Shr Cash For Transaction Value Of About $9.2 Bln 11/14/2025 6:50:13 AM

Cidara Therapeutics Shares Surge In After-Hours On Report Of Nearing Merck Deal 11/13/2025 9:46:00 PM

- 1
- 2
- 3
- Next »

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap